Spok Holdings, Inc
Business
Spok Holdings, Inc. provides clinical communication and collaboration solutions that deliver clinical information to care teams to improve patient outcomes. It offers wireless messaging and pager products (including GenA pagers), the Spok Care Connect® software suite (contact center, clinical alerting, mobile communications, public safety) and related professional, hosted and maintenance services. The business operates across wireless, software and services lines and targets three market segments: healthcare, government and large enterprise. Spok distributes primarily through a direct sales force and indirect alliance partners, mainly in the United States with limited operations in Europe, Canada, Australia, Asia and the Middle East.
Summary from filing dated 2025-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 140 | 138 | 139 | 135 | 142 | |
| Cost of revenue (exclusive of items shown separately below) | 30 | 29 | 27 | 28 | 32 | |
| Research and development | 12 | 12 | 11 | 14 | 18 | |
| Technology operations | 25 | 26 | 27 | 27 | 29 | |
| Selling and marketing | 18 | 16 | 17 | 16 | 21 | |
| General and administrative | 32 | 31 | 31 | 38 | 44 | |
| Severance and restructuring | 458,000 | 1 | 573,000 | 7 | 320,000 | |
| Depreciation and accretion | 3 | 4 | 4 | 4 | 10 | |
| Total operating expenses | 120 | 119 | 118 | 134 | 170 | |
| Operating income | 20 | 19 | 21 | 238,000 | −28 | |
| Interest income | 820,000 | 1 | 1 | 592,000 | — | |
| Other income (expense) | 900,000 | −100,000 | 0 | 167,000 | 66,000 | |
| Income before income taxes | 21 | 20 | 22 | 997,000 | −27 | |
| Provision for income taxes | −6 | −5 | −7 | 21 | 5 | |
| Net income | 16 | 15 | 16 | 22 | −22 | |
| Basic net income per common share (in usd per share) | 0.77 | 0.74 | 0.79 | 1.11 | −1.14 | |
| Diluted net income per common share (in usd per share) | 0.75 | 0.73 | 0.77 | 1.09 | −1.14 | |
| Basic weighted average common shares outstanding (in shares) | 21 | 20 | 20 | 20 | 19 | |
| Diluted weighted average common shares outstanding (in shares) | 21 | 21 | 20 | 20 | 19 | |
| Dividends declared (in usd per share) | 1.25 | 1.25 | 1.25 | 1.25 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2022 2022-05-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 25 | 29 | 32 | 36 | — | |
| Accounts receivable, net | 23 | 22 | 23 | 27 | — | |
| Prepaid expenses | 9 | 9 | 8 | 7 | — | |
| Other current assets | 1 | 840,000 | 704,000 | 587,000 | — | |
| Total current assets | 58 | 61 | 64 | 70 | — | |
| Property and equipment, net | 6 | 6 | 7 | 8 | — | |
| Operating lease right-of-use assets | 6 | 8 | 11 | 14 | 3 | |
| Goodwill | 99 | 99 | 99 | 99 | — | |
| Deferred income tax assets, net | 37 | 42 | 46 | 52 | — | |
| Other non-current assets | 322,000 | 744,000 | 510,000 | 754,000 | — | |
| Total non-current assets | 148 | 156 | 164 | 174 | — | |
| TOTAL ASSETS | 206 | 217 | 228 | 244 | — | |
| Accounts payable | 4 | 6 | 6 | — | — | |
| Accrued compensation and benefits | 7 | 7 | 7 | 12 | — | |
| Deferred revenue | 30 | 28 | 26 | 27 | — | |
| Operating lease liabilities | 3 | 3 | 4 | 5 | — | |
| Other current liabilities | 5 | 5 | 4 | 5 | — | |
| Total current liabilities | 49 | 49 | 48 | 54 | — | |
| Asset retirement obligations | 5 | 6 | 7 | 7 | — | |
| Operating lease liabilities | 4 | 6 | 7 | 11 | — | |
| Other non-current liabilities | 1 | 2 | 2 | 1 | — | |
| Total non-current liabilities | 11 | 14 | 16 | 19 | — | |
| TOTAL LIABILITIES | 60 | 62 | 64 | 73 | — | |
| COMMITMENTS AND CONTINGENCIES (Note $10) | — | — | — | — | — | |
| Preferred stock$0.0001 par value; 25,000,000 shares authorized; no shares issued or outstanding | 0 | 0 | 0 | 0 | — | |
| Common stock$0.0001 par value; 75,000,000 shares authorized; 20,610,364 and 20,284,177 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively. | 2,000 | 2,000 | 2,000 | 2,000 | — | |
| Additional paid-in capital | 108 | 106 | 103 | 100 | — | |
| Accumulated other comprehensive loss | −2 | −2 | −2 | −2 | — | |
| Retained earnings | 40 | 51 | 63 | 73 | — | |
| TOTAL STOCKHOLDERS EQUITY | 146 | 155 | 164 | 171 | — | |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 206 | 217 | 228 | 244 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Deferred income tax expense | 5 | 5 | 6 | 903,000 | −5 | |
| Stock-based compensation | 5 | 5 | 4 | 4 | 7 | |
| Gain on sale of domain name | −701,000 | 0 | 0 | — | — | |
| Gain on asset retirement obligation settlement | 123,000 | 0 | 0 | — | — | |
| Provisions for credit losses, service credits and other | 1 | 846,000 | 950,000 | 2 | 1 | |
| Accounts receivable | −2 | 506,000 | 3 | −2 | 2 | |
| Prepaid expenses and other assets | 652,000 | −2 | −909,000 | −88,000 | 3 | |
| Net operating lease liabilities | −62,000 | −36,000 | −1 | 357,000 | 763,000 | |
| Accounts payable and other liabilities | −2 | −1 | −5 | −2 | −679,000 | |
| Deferred revenue | 2 | 2 | −559,000 | 118,000 | −3 | |
| Net cash provided by operating activities | 29 | 29 | 26 | 6 | 8 | |
| Purchases of property and equipment | −4 | −3 | −3 | −4 | −4 | |
| Proceeds from sale of domain name | 701,000 | 0 | 0 | — | — | |
| Net cash used in investing activities | −3 | −3 | −3 | 11 | −225,000 | |
| Cash distributions to stockholders | −27 | −26 | −26 | −25 | −10 | |
| Proceeds from issuance of common stock under the Employee Stock Purchase Plan | 312,000 | 272,000 | 210,000 | 0 | 132,000 | |
| Purchase of common stock for tax withholding on vested equity awards | −3 | −2 | −1 | −1 | −2 | |
| Net cash used in financing activities | −30 | −29 | −27 | −26 | −12 | |
| Effect of exchange rate on cash and cash equivalents | 28,000 | −20,000 | 145,000 | −321,000 | −136,000 | |
| Net decrease in cash and cash equivalents | −4 | −3 | −4 | −9 | −4 |